GWLLOTCFood and Kindred ProductsFiscal year ends December 31
GOLDENWELL BIOTECH, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026
- Market cap
- $64.35M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Goldenwell Biotech has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Goldenwell Biotech filed with the SEC
FORM 8-K
Event dated Oct 8, 2026, from SEC EDGAR
FORM 8-K
Event dated Sep 27, 2026, from SEC EDGAR
FORM 8-K
Event dated May 19, 2026, from SEC EDGAR
FORM 8-K
Event dated Jul 24, 2025, from SEC EDGAR
FORM 8-K
Event dated Jan 23, 2025, from SEC EDGAR
FORM 8-K
Event dated Nov 13, 2024, from SEC EDGAR
FORM 8-K
Event dated May 15, 2024, from SEC EDGAR
FORM 8-K
Event dated Sep 8, 2021, from SEC EDGAR